Bracco Imaging has acquired real-time fluorescence image-guided surgery firm SurgVision.
Current modalities and products do not always provide adequate views for surgeons during these procedures, according to SurgVision. SurgVision's intraoperative optical technology combines a targeted imaging agent and a device to visualize and differentiate between tumors and surrounding tissue during oncology surgical procedures.
With the acquisition of SurgVision, Bracco expands its oncology product portfolio and seeks to address an unmet medical need for oncology patients who have to undergo tumor removal surgery, said Fulvio Renoldi Bracco, Bracco Imaging CEO.
At the same time, the addition of SurgVision is designed to accelerate the development of the projects currently in Bracco's R&D pipeline, added Micol Fornaroli, chief strategy officer.
